RADA16 for same-day aquablation surgery

This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.

This study tests whether giving a medicine called tranexamic acid before Aquablation surgery helps reduce bleeding during the procedure. The goal is to see if it makes the surgery safer and reduces blood loss for men with an enlarged prostate.

This trial combines a biopsy (tissue sampling) with a heat-based ablation procedure in one visit to diagnose and treat early prostate cancer while also relieving severe urinary symptoms. It may help patients who need quick treatment and early discharge.

This study compares two minimally invasive treatments for an enlarged prostate that is blocking urine flow. It aims to see which method—Rezūm (water vapor therapy) or EchoLaser (laser using ultrasound guidance)—better relieves urinary symptoms and improves quality of life.

This trial compares two catheter-based treatments—TUMT and PAE—to see which better reduces severe urinary symptoms caused by an enlarged prostate (BPH). It may help you choose a treatment option if medicines are not suitable or you still have significant symptoms.

This trial tests whether a medicine called tranexamic acid, given during surgery to remove part of the prostate, can reduce bleeding. If you are scheduled for this type of prostate surgery, this treatment might help make the procedure safer and improve recovery.